Focal Therapeutics
Latest round
- Series C
Last raised
- Aug 2013
Total raised
- $7.8M
Investors
- 2
About Focal Therapeutics
Focal Therapeutics, Inc.Founded in 2007 and headquartered in Aliso Viejo, US, Focal Therapeutics, Inc. offers innovative solutions for breast cancer treatment. In September 2018, Hologic, Inc. acquired the company for USD 125 mn.Focal Therapeutics, Inc. specializes in innovative breast surgery solutions aimed at enhancing the detection, diagnosis, and treatment of breast cancer. Their core product offerings include the Faxitron Path+ system, which provides high-resolution imaging with 10X geometric magnification, and the Trident® HD Specimen Radiography System, known for its rapid imaging capabilities. Additionally, they offer the LOCalizer wire-free guidance system that utilizes miniature radiofrequency identification tags for non-palpable breast lesion localization, and the TruNode system, a wireless gamma probe for radio-guided surgical procedures. Hologic’s products are designed to maximize precision while minimizing patient anxiety, supporting clinicians in delivering optimal care.Hologic’s revenue generation is primarily driven by the sale of advanced breast health technology and surgical devices to healthcare institutions. Transactions often occur through direct sales to hospitals and clinics, where clients purchase products like the Trident® HD and the Faxitron Path+ systems for their surgical and diagnostic needs. The company may also engage in partnerships with healthcare providers to integrate their systems into existing workflows. Hologic’s product suite, which includes flagship products, significantly influences their revenue structure, with healthcare institutions relying on these devices for both routine and specialized breast procedures.Focal Therapeutics, Inc. plans to leverage the recent acquisition by Hologic, Inc. to enhance its product offerings and expand its market presence. The company also aims to explore expansion into new geographic markets, particularly targeting regions in Europe and Asia over the next few years.
Who invested in Focal Therapeutics
2 investors across 1 round
See all investors in Focal Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 13, 2013
Amount
$7.8M
Investors
Questions about Focal Therapeutics
Who invested in Focal Therapeutics?
Focal Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Focal Therapeutics raised?
Focal Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Focal Therapeutics last raise money?
Focal Therapeutics's most recent round on record is a Series C, in Aug 2013.
What does Focal Therapeutics do?
Focal Therapeutics is a medical devices & equipment company.
Where is Focal Therapeutics headquartered?
Focal Therapeutics is headquartered in Aliso Viejo, US.
Which VCs invest in companies like Focal Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Focal Therapeutics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Focal Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.